Lv1
18 积分 2024-02-05 加入
Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy
2小时前
求助中
Messenger interference RNA therapies targeting apolipoprotein C-III and angiopoietin-like protein 3 for mixed hyperlipidemia: the future of plozasiran and zodasiran
24天前
已完结
Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia
1个月前
已完结
Design, Biological Characterization, and Discovery of Novel Cyclohexenyl Derivatives as Kinesin KIF18A Inhibitors for the Treatment of Ovarian Cancer
1个月前
已完结
Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk
1个月前
已完结
Lipoprotein(a) and ethnicities
2个月前
已完结
Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk
2个月前
已完结
Asundexian versus Apixaban in Patients with Atrial Fibrillation
2个月前
已完结
Pharmacological and clinical appraisal of factor XI inhibitor drugs
2个月前
已完结
Single‐Dose Pharmacokinetics and Pharmacodynamics of Transthyretin Targeting N‐acetylgalactosamine–Small Interfering Ribonucleic Acid Conjugate, Vutrisiran, in Healthy Subjects
2个月前
已完结
皖公网安备34019202002308
